Suchergebnisse - "Subklewe, Marion"

PubPharm (327)

31

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

enthalten in: Nature biotechnology | 2023

von Gottschlich, A. | Thomas, M. | Grünmeier, R. | +43

32

Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy

enthalten in: Journal for immunotherapy of cancer | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

33

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL : a GLA/DRST registry study

enthalten in: Blood advances | 2023

von Schubert, M. | Bethge, W. | Ayuk, F. | +14

34

The race is on : bispecifics vs CAR T cells in B-cell lymphoma

enthalten in: Blood advances | 2023

von Gurumurthi, A. | Westin, J. | Subklewe, M.

35

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL : a GLA/DRST registry study

enthalten in: Blood advances | October 13, 2023

von Schubert, M. | Bethge, W. | Ayuk, F. | +14

36

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

enthalten in: Science advances | 2023

von Rejeski, K. | Perez, A. | Iacoboni, G. | +23

37

Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy

enthalten in: Cytotherapy | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

38

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

CommentIn: Blood. 2023 Sep 7;142(10):859-861. - PMID 37676695

39

Standardising acute myeloid leukaemia classification systems : a perspective from a panel of international experts

enthalten in: The Lancet. Haematology | 2023

von Shallis, R. | Daver, N. | Altman, J. | +38

40

Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

enthalten in: Journal for immunotherapy of cancer | 2023

von Shah, B. | Cassaday, R. | Park, J. | +26